Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prescription Strategies of Amikacin in Intensive Care Patients on Renal Replacement Therapy: an Observational Prospective Multicenter Study

NCT04322019 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT04322019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04322019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prescription Strategies of Amikacin in Intensive Care Patients on Renal Replacement Therapy: an Observational Prospective Multicenter Study
Lead sponsor
CHU de Reims
Phase
Observational
Overall status
Completed
Start date
May 25, 2020
Completion date
May 16, 2022
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amikacin treatment